Idarubicin-induced pigmentary changes of the nails.

Borecky Dj, Stephenson Jj, Keeling Jh, SJ Vukelja

PubMed · 1997 · 15 citations · 0 references

Concepts

Abstract

A case of acute myelocytic leukemia of the FAB-M2 subtype in a patient who experienced pigmentary nail changes in conjunction with idarubicin therapy is presented. Although doxorubicin and daunorubicin have been reported to cause nail pigmentation changes, this is the first case report to describe these changes with idarubicin.